Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

LKL collaborates with FKS Medical Care to market medical device

TheEdge Wed, Sep 26, 2018 09:13pm - 1 year ago

KUALA LUMPUR (Sept 26): LKL International Bhd, through its subsidiary LKL Advance Metaltech Sdn Bhd, has inked a collaborative memorandum of understanding (MoU) with FKS Medical Care Sdn Bhd to cooperate in the market development of Sanuwave Health Inc's dermaPACE, an advanced medical device used to treat acute and chronic wounds.

In a filing with Bursa Malaysia today, LKL said under the two-year MoU, FKS will be responsible for introducing dermaPACE into Malaysia, and both FKS and LKL Advance Metaltech will cooperate together to promote and market the device in the country.

FKS Medical Care is a subsidiary of FKS-Life & Health Medical Care Inc, a medical appliance and device manufacturer and distributor based in California, the US.

LKL said dermaPACE is a shock wave technology using a patented system of non-invasive, high energy, acoustic shock waves for regenerative medicine and other applications.

The dermaPACE system is cleared by the US Food and Drug Administration for marketing in the US for the treatment of diabetic foot ulcers. The system is CE Marked for the European Union, and licensed in Canada, Australia, New Zealand and South Korea for acute and chronic conditions of the skin and subcutaneous soft tissue indications.

LKL managing director Lim Kon Lian said he is optimistic the device will be well received in Malaysia, and provide more advanced wound care treatment for conditions such as post traumatic wounds, burns and diabetic ulcers, bringing better healthcare and greater quality of life to patients.

"Additionally, the inclusion of dermaPACE to our medical devices portfolio is in line with our strategy to provide comprehensive solutions to our customers in the healthcare sector.

"We would also continue to identify opportunities to introduce more high-value medical products to the Malaysia market," he said.

LKL shares closed up one sen or 7.4% to 14.5 sen today, for a market capitalisation of RM62 million.

Related Stocks

BURSA 10.360
LKL 1.430


Login to comment.